| RS201744761 |
FIG4
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 11, Charcot-Marie-Tooth disease type 4 |
| RS201745292 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyl transferase II deficiency |
| RS201745746 |
LRP5
|
Health Risk |
Likely pathogenic |
Exudative vitreoretinopathy 4, Exudative vitreoretinopathy 4 |
| RS201745796 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, OTOF-related disorder |
| RS201745826 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia type 2A |
| RS201746137 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS201746407 |
MUC5B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201746408 |
MYH14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 4A, Autosomal dominant nonsyndromic hearing loss 4A |
| RS201746476 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
PIEZO1-related disorder, PIEZO1-related disorder |
| RS201747279 |
CNGA3
|
Health Risk |
Pathogenic |
Retinal dystrophy, Achromatopsia 2 |
| RS201747375 |
TRPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1C, TRPM1-related disorder |
| RS201747452 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Inborn genetic diseases |
| RS201748079 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS201748228 |
PROM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stargardt disease 4, Retinal macular dystrophy type 2 |
| RS2017487230 |
NFIX
|
Health Risk |
Pathogenic |
— |
| RS2017489032 |
NFIX
|
Health Risk |
Conflicting classifications of pathogenicity |
Marshall-Smith syndrome, Malan overgrowth syndrome |
| RS201749120 |
LRP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cenani-Lenz syndactyly syndrome, Sclerosteosis 2 |
| RS201749138 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS201749187 |
NBEAL2
|
Health Risk |
Conflicting classifications of pathogenicity |
NBEAL2-related disorder, Inborn genetic diseases |
| RS201749293 |
HNF4A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201749357 |
PTH1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Connective tissue disorder |
| RS201749864 |
DNMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory neuropathy-deafness-dementia syndrome, Inborn genetic diseases |
| RS201749977 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
POLG-related disorder, Progressive sclerosing poliodystrophy |
| RS201750183 |
MUC5B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201750214 |
C1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, C1S-related disorder |
| RS201750304 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS201750444 |
P3H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 8, Osteogenesis Imperfecta |
| RS201750697 |
SIAE
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201751275 |
AFG2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Inborn genetic diseases |
| RS201751544 |
HPD
|
Health Risk |
Likely pathogenic |
Hawkinsinuria, Tyrosinemia type III |
| RS2017517553 |
WDR72
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta hypomaturation type 2A3, Amelogenesis imperfecta hypomaturation type 2A3 |
| RS201751992 |
NARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 24, Inborn genetic diseases |
| RS201752014 |
MCFD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor 5 and Factor VIII, combined deficiency of |
| RS201752283 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Glioma susceptibility 1 |
| RS201752905 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS201753022 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 11, Autosomal recessive nonsyndromic hearing loss 2 |
| RS201753066 |
BBIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BBIP1-related disorder, BBIP1-related disorder |
| RS201753098 |
AIFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth Neuropathy X, Combined oxidative phosphorylation deficiency |
| RS201753270 |
PUS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, lactic acidosis |
| RS201753350 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome |
| RS201753421 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS201753429 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Sudden cardiac death, Dilated cardiomyopathy 1D |
| RS201753781 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1O, Hypertrichotic osteochondrodysplasia Cantu type |
| RS201754030 |
TSFM
|
Health Risk |
Pathogenic/Likely pathogenic |
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3, Primary dilated cardiomyopathy |
| RS201754358 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS201754378 |
NDUFAF4
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS201754399 |
CFB
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration |
| RS201754491 |
ADGRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201754555 |
DNAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kartagener syndrome, Primary ciliary dyskinesia |
| RS201754946 |
KRT4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, White sponge nevus 1 |
| RS201755444 |
MATN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple epiphyseal dysplasia type 5, Connective tissue disorder |
| RS201756168 |
SOS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 9, Cardiovascular phenotype |
| RS201756175 |
ATP13A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Kufor-Rakeb syndrome, Autosomal recessive spastic paraplegia type 78 |
| RS201756421 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS201756674 |
DTNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction 1, Left ventricular noncompaction 1 |
| RS201757205 |
POLR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201757275 |
EPG5
|
Health Risk |
Pathogenic/Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS201757586 |
ODAD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS201758122 |
MCCC1
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylcrotonyl-CoA carboxylase 1 deficiency, Inborn genetic diseases |
| RS201758263 |
VARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
VARS2-related disorder, VARS2-related disorder |
| RS201758329 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS201758481 |
NEU1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, NEU1-related disorder |
| RS201758531 |
DST
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 3, localized or generalized intermediate |
| RS201758548 |
GBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type IV |
| RS201759367 |
NOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Blau syndrome, Inflammatory bowel disease 1 |
| RS201759867 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS201760019 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS201760623 |
POC1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 20, Inborn genetic diseases |
| RS201760746 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS201761081 |
ABCC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201761335 |
MYT1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Early onset severe obesity, Early onset severe obesity |
| RS201761802 |
DMP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatemic rickets, autosomal recessive |
| RS201761868 |
TGFB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Loeys-Dietz syndrome 4, Familial thoracic aortic aneurysm and aortic dissection |
| RS201762017 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontometaphyseal dysplasia, Heterotopia |
| RS201762439 |
MYH14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 4A, Autosomal dominant nonsyndromic hearing loss 4A |
| RS201762532 |
GFER
|
Health Risk |
Likely pathogenic |
— |
| RS201762568 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Distal myopathy with posterior leg and anterior hand involvement, Hypertrophic cardiomyopathy 26 |
| RS201762714 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS201762781 |
CHRNG
|
Health Risk |
Pathogenic |
Autosomal recessive multiple pterygium syndrome, Autosomal recessive multiple pterygium syndrome |
| RS201762847 |
A2ML1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201762858 |
KMT2C
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS201762900 |
ABCA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease due to ABCA3 deficiency, Interstitial lung disease due to ABCA3 deficiency |
| RS201763265 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201763437 |
COL4A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201763667 |
SNTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS201763720 |
DNM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Centronuclear myopathy, Charcot-Marie-Tooth disease dominant intermediate B |
| RS201763918 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1D, Autosomal recessive nonsyndromic hearing loss 12 |
| RS201763950 |
ATP7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Menkes kinky-hair syndrome, X-linked distal spinal muscular atrophy type 3 |
| RS201764050 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS201764098 |
SKIC2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201764222 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS201764494 |
MUC5B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201764553 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS201764637 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS201764744 |
PLCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 12 |
| RS201764931 |
FH
|
Health Risk |
Likely pathogenic |
— |
| RS201765331 |
CD36
|
Health Risk |
Likely pathogenic |
Inherited bleeding disorder, platelet-type |
| RS201765507 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS201765587 |
PARN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal recessive 6 |
| RS201765665 |
SLC1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 6, Episodic ataxia type 6 |